Volpone John
- SEC CIK
- 0002081729
Latest role at each company
- XFOR X4 Pharmaceuticals, IncPresidentas of Aug 13, 2026
Trades
Every Form 4 that lists Volpone John as a reporting owner, including filings made jointly with others. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Company | Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| XFORX4 Pharmaceuticals, Inc | Aug 13, 20264:13 PM ET | Aug 12, 2026 | Volpone JohnPresident | SSaleCommon Stock | −24.58K | $4.4445 | −$109.23K | 265.31K | −8.5% | SEC |